KR950007878A - 생물분해성 이식제 전구체 - Google Patents

생물분해성 이식제 전구체 Download PDF

Info

Publication number
KR950007878A
KR950007878A KR1019940019893A KR19940019893A KR950007878A KR 950007878 A KR950007878 A KR 950007878A KR 1019940019893 A KR1019940019893 A KR 1019940019893A KR 19940019893 A KR19940019893 A KR 19940019893A KR 950007878 A KR950007878 A KR 950007878A
Authority
KR
South Korea
Prior art keywords
implant precursor
implant
precursor
polymer
polymer solution
Prior art date
Application number
KR1019940019893A
Other languages
English (en)
Other versions
KR100248326B1 (ko
Inventor
에스. 피터손 케네디
엘. 둔 리차드
피. 콕스 찰스
엘. 노오톤 리차드
엠. 폴손 알랜
케이. 로우 브라이언
디. 스완봄 데랄
Original Assignee
엘. 둔 리차드
아트릭스 라보라토리스, 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엘. 둔 리차드, 아트릭스 라보라토리스, 아이엔씨. filed Critical 엘. 둔 리차드
Publication of KR950007878A publication Critical patent/KR950007878A/ko
Priority to KR1019990049028A priority Critical patent/KR100263443B1/ko
Application granted granted Critical
Publication of KR100248326B1 publication Critical patent/KR100248326B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/12—Stiffening bandages containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/08—Coating a former, core or other substrate by spraying or fluidisation, e.g. spraying powder
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/12—Spreading-out the material on a substrate, e.g. on the surface of a liquid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C67/00—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00
    • B29C67/02—Moulding by agglomerating
    • B29C67/06—Coagulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037—Other properties
    • B29K2995/0056—Biocompatible, e.g. biopolymers or bioelastomers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037—Other properties
    • B29K2995/0059—Degradable
    • B29K2995/006—Bio-degradable, e.g. bioabsorbable, bioresorbable or bioerodible

Abstract

본 발명은 외부 주머니와 액체 내용물로 구성되는 두부분 구조물을 갖는 생물 분해성 이식제 전구체에 관한 것이다.
이식제 전구체는 생물분해성이며, 수응고성인 열가소성 중합체 및 물 혼화성 유기용매로 구성되어 있다.
동물에서 이식부위에 투여되면, 이식제 전구체는 주위 조직액으로 유기용매의 분산 및 중합체의 응고에 의하여 고체 미세다공성 매트릭스로 제위치에서 응고하게 된다.
또한 본 발명은 이식제 전구체를 제조하는 방법, 상기 전구체를 형성하는 장치 및 상기 장치를 갖는 키트를 포함한다.
또한 본 발명은 예컨대 세포성장 및 조직재생, 상처 및 기관회복, 신경재생, 연질 및 경질 조직 재생등을 증대시키기 위하여 동물에서 조직결함부를 치료하고, 조직 또는 기관에 생물활성제를 이송하고, 기타 이와 유사한 치료를 위하여 이식제 전구체를 사용하는 방법을 제공하여 준다.

Description

생물분해성 이식제 전구체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 본 발명의 전구체 형성장치의 일예의 사시도,
제2도는 일련의 스페이서의 배치를 보여주는 제1도의 전구체 형성장치의 사시도,
제3도는 스페이서 사이의 대역에 수성층과 중합체 용액층의 배치를 보여주는 제2도의 전구체 형성장치의 측면도,
제4도는 이식제 전구체의 형성중 페쇄위치에 전구체 형성장치를 보여주는 제3도의 전구체 형성장치의 측면도.

Claims (37)

  1. 외부 주머니와 액체 내용물로 이루어지는 두부분 구조물을 가지며, 생물화합성, 생물분해성, 수응고성의 열가소성 중랍체와 제약적으로 허용가능한 수용성 유기용매의 혼합물로 구성되는, 동물에서 조직결함부에 이식하기 위한 이식제 전구체.
  2. 제1항에 있어서, 이식제 전구체의 액체 내용물은 물의 형태로 부터 끈끈한 형태의 점성을 가지며, 외부 주머니는 젤라틴 형태로 부터 왁스 형태의 점성을 가짐을 특징으로 하는 이식제 전구체.
  3. 제1항에 있어서, 이식제 전구체는 형성되어 그후 수성매체와의 접촉이 없는 경우 약 30-90분 후에 완전 액채형태로 복귀될 수 있음을 특징으로 하는 이식제 전구체.
  4. 제1항에 있어서, 열가소성 중합체는 폴리락티드, 폴리글리콜라이드, 폴리카프로락톤, 폴리언하이드라이드, 폴리아미드, 폴리우레탄, 폴리에스테르아미드, 폴리오르로에스테르, 폴리디옥사논, 폴리아세탈, 폴리케탈, 폴리카보네이트, 폴리오르트카보네이트, 폴리포스파젠, 폴리하이드록시부티레이트, 폴리하이드록시발레레이트, 폴리알킬렌 옥살레이트, 폴리알킬렌 석시네이드, 폴리말린산, 폴리아미노산, 폴리메털 비닐에테르, 키틴, 키토산 및 공중합체, 테르폴리머 및 이들의 화합물로 구성되는 기로부터 선택됨을 특징으로 하는 이식제 진구체.
  5. 제1항에 있어서, 용매는 N-메틸-2-피롤리돈, 2-피롤리돈, 에탄올, 프로필렌 글리콜, 프로필렌 카보네이트, 아세톤, 아세트산, 에틸아세테이트, 에틸 락테이트, 메틸 아세테이트, 메틸에틸케톤, 디메틸포름아미드, 디메틸 설폭사이드, 디메틸 설폰, 테트라하이드로푸란, 카프로락탐, 데실메틸설폭사이드, 올레인산, N, N-디에틸-m-톨루아미드 및 1-도데실아자사이클로헵탄-2-온 및 이들의 화합물로 구성되는 기로부터 선택됨을 특징으로 하는 이식제 전구체.
  6. 제1항에 있어서, 설탕, 염, 수용성 중합체 및 수용성 물질로 신속히 분해되는 수불용성 물지로 구성되는 기로부터 선택되는 기공형성제를 또한 포함함을 특징으로 하는 이식제 전구체.
  7. 제1항에 있어서, 항균제, 항진균제 및 항바이러스제로 구성되는 기로부터 선택되는 생물활성제를 또한 포함함을 특징으로 하는 이식제 전구체.
  8. 제1항에 있어서, 소염제, 구충제, 항종양제, 진통제, 마취제, 왁찐, 중추신경계 약제, 성장인자, 흐르몬, 항히스타민, 뼈 형성 유도제, 심장혈관제, 항궤양제, 기관지 확장제, 혈관확장제, 산아조절제 및 임신촉진제로 구성되는 기로부터 선택되는 생물 활성제를 또한 포함함을 특징으로 하는 이식제 전구체.
  9. 제1항에 있어서, 생체내에서 이식제 매트릭스로 부터 생물활성제의 방출속도를 조절하기 위한 방출속도 조절제를 또한 포함함을 특징으로 하는 이식제 전구체.
  10. 제9항에 있어서, 방출속도 조절제는 모노카르복실산의 에스테르, 디카르복실산의 에스테르, 트리카르복실산의 에스테르, 폴리하이드록시 알콜, 지방산, 글리세롤의 트리에스테르, 스테롤, 알콜 및 이들의 화합물로 구성되는 기로부터 선택됨을 특징으로 하는 이식제 전구체.
  11. 제10항에 있어서, 방출속도 조절제는 2-에톡시에틸 아세테이트, 메딜아세테이트, 에틸아세테이트, 디메틸 프탈레이트, 디메틸 프탈레이트, 디부틸 프탈레이트, 디메틸 아디페이트, 디메틸 석시네이트, 디메틸 옥살레이트, 디메틸 시트레이트, 트리에틸 시트레이트, 아세틸 트리부틸 시트레이트, 아세틸 트리에딜 시트레이트, 글리셀롤 트리아세테이트, 디(n-부틸) 세버케이트, 프로필렌 글리콜, 폴리에틸렌 글리콜, 글리세린, 소르비톨, 트리글리세라이드, 에폭시화 콩기름, 콜레스테롤, C6-C12알칸올, 2-에톡시 에탄올 또는 이들의 화합물로 구성되는 기로부터 선택됨을 특징으로 하는 이식제 전구체.
  12. 제10항에 있어서, 방출속도 조절제는 디메틸 시트레이트, 트리에틸 시트레이트, 에틸 헵타노에이트, 글리세린, 헥산디올 및 이들의 화합물로 구성되는 기로부터 선택됨을 특징으로 하는 이식제 전구체.
  13. (a) 유효량의 수성매체를 고체 지지기질의 표면에 가하여 수성층을 형성하고; (b) 수응고성, 생물화합성, 생물분해성의 열가소성 중합체 및 물 혼화성이며 제약적으로 허용가능한 유기용매로 구성되는 유효량의 액체 중합체 용액을 수성층에 분배하고; (c) 유효량의 수성매체를 중합체 용액의 표면에 가하고; (d) 수성매체에 인접한중합체를 방치하여 응고시켜 외부 주머니와 액체 내용물로 이루어지는 두부분 구조물로 구성되는 이식제 전구체를 형성하되; 상기 단계 (a) 및 (c)에서 수성매체는 중합체의 표면을 응고시켜 이식제 전구체의 외부 주머니를 형성하기에 효과적인 양으로 가함을 특징으로 하는 이식제 전구체를 제조하는 방법.
  14. 제13항에 있어서, 약400-1500㎛의 두께로 이식제 전구체를 유지시키는 단계 (e)를 또한 포함함을 특징으로 하는 이식제 전구체를 제조하는 방법.
  15. 제13항에 있어서, 이식제 전구체의 두께는 단계 (d)중에 응고되는 중합체 용액을 압착시킴으로서 유지시킴을 특징으로 하는 이식제 전구체를 제조하는 방법.
  16. 제13항에 있어서, 이식제 전구체를 생체외에서 형성함을 특징으로 하는 이식제 전구체를 제조하는 방법.
  17. 제13항에 있어서, 지지기질은 유리, 다공성 플라스틱, 소결 스테인레스강, 자기, 뼈 재료, 뼈, 산화셀룰로오스 기포, 생물화합성 중합체 기포, 생물화합성 중합체의 입자, 트리칼슘 포스페이트 및 혈액물질로 구성됨을 특징으로 하는 이식제 전구체를 제조하는 방법.
  18. 제13항에 있어서, 이식제 전구체를 생체내에서 형성함을 특징으로 하는 이식제 전구체를 제조하는 방법.
  19. 제13항에 있어서, 지지기질은 경질조직임을 특징으로 하는 이식제 전구체를 제조하는 방법.
  20. 제19항에 있어서, 지지기질은 뼈 조직임을 특징으로 하는 이식제 전구체를 제조하는 방법.
  21. 제13항에 있어서, 단계 (a)전에, (i) 소량이지만 유효량의 수성매체를 지지 기질의 표면에 하나의 층으로 가하고; (ii) 생물화합성, 생물분해성, 수응고성의 열가소성 중합체 및 제약적으로 허용가능한 수용성 유기용매로 구성되는 유효량의 중합체 용액을 수성층에 분배하여 그 위에 대역을 한정하는 선을 형성하고; (iii) 유효량의 수성매체를 선의 표면에 가하고; (iv) 중합체를 방치하여 응고시켜 액채 내용물을 갖는 외부 주머니로 이루어지는 두부분 구조물로 구성되는 경계선을 형성하는 단계를 또한 포함하며; 이식제 전구체를 경계선에 의하여 한정된 대역내에서 지지기질에 형성함을 특징으로 하는 이식제 전구체를 제조하는 방법.
  22. 제13항에 있어서, 단계 (a)전에, 생물흡수성 또는 생물부식성 재료로 구성되는 지지층을 조직결합부의 표면에 적용되는 단계를 또한 포함하며; 이식제 전구체를 지지층의 표면에 형성함을 특징으로 하는 이식제 전구체를 제조하는 방법.
  23. 제22항에 있어서, 지지층은 조직결함부의 표면에 피복되는 생물화합성, 생물분해성, 수응고성의 열가소성중합체와 제약적으로 허용가능한 물 혼화성 유기 용매로 이루어지는 중합체 용액으로 구성됨을 특징으로 하는 이식제 전구체를 제조하는 방법.
  24. 제23항에 있어서, 가스형성제를 중합체 용액에 혼합하고, 지지층을 다공성 기포형 구조로 형성하는 것을 또한 포함함을 특징으로 하는 이식제 전구체를 제조하는 방법.
  25. 제22항에 있어서, 지지층은 선천적인 몸체 물질로 구성됨을 특징으로 하는 이식제 전구체를 제조하는 방법.
  26. 제22항에 있어서, 지지층은 응혈로 구성됨을 특징으로 하는 이식제 전구체를 제조하는 방법.
  27. 제22항에 있어서, 지지층은 산화 셀룰로오스 또는 젤라틴으로 구성됨을 특징으로 하는 이식제 전구체를 제조하는 방법.
  28. 제22항에 있어서, 지지층은 수용성 중합체로 구성됨을 특징으로 하는 이식제 전구체를 제조하는 방법.
  29. 제22항에 있어서, 지지층은 트리칼슘 포스페이트, 칼슘 설페이트 또는 하이드록시 아파다이트로 구성됨을 특징으로 하는 이식제 전구체를 제조하는 방법.
  30. 제28항에 있어서, 지지층은 폴리락티드, 폴리글리클라이드, 폴리카프로락톤, 폴리언하이드라이드, 폴리아미드, 폴리우레탄, 폴리에스테르아미드, 폴리오르토에스테르, 폴리디옥사논, 폴리아세탈, 폴리케탈, 폴리카보네이트, 폴리오르토카보네이트, 폴리포스파젠, 폴리하이드록시부티레이트, 폴리하이드록시발레레이트, 폴리알킬렌 옥살레이트, 폴리알킬렌 석시네이트, 폴리말린산, 폴리에틸렌 글리콜, 하이드록시프로필 셀룰로오스, 폴리비닐 피롤리돈, 폴리아미노산, 폴리메틸 비닐 에테르, 키틴, 키토산 및 공중합체, 테르폴리머 및 이들의 화합물로 구성됨을 특징으로 하는 이식제 전구체를 제조하는 방법.
  31. (a) 외부 주머니와 액체 내용물로 이루어지는 두부분 구조물을 가지며, 생물화합성, 생물분해성, 수응고성의 열가소성 중합체와 제약적으로 허용가능한 수용성 유기용매의 혼합물로 구성되는 이식제 전구체를 조직 결함부에 투여하고; (b) 조직 결함부를 치료하는 데 유효한 이식제 전구체를 방치하여 그 위치에서 응고시켜 고체 미세다공성 매트릭스로 구성되는 이식제가 형성되도록 구성시킨 동물에서 조직 결함부를 치료하는 방법.
  32. 제31항에 있어서, 이식제 전구체는 항세균제, 항진균제 및 항바이러스제로 구성되는 기로부터 선택되는 생물활성제를 또한 포함함을 특징으로 하는 조직 결함부를 치료하는 방법.
  33. 제32항에 있어서, 이식제 전구체는 소염제, 구충제, 항종양제, 진통제, 마취제, 왁찐, 중추신경계 약제, 성장인자, 호르몬, 항히스타민, 뼈 형성 유도제, 심장혈관제, 항궤양제, 기관지 확장제, 혈관 확장제, 산아조절제 및 임신촉진제로 구성되는 기로부터 선택되는 생물활성제를 또한 포함함을 특징으로 하는 조직결함부를 치료하는 방법.
  34. 제32항에 있어서, 이식제 전구체는 생체내에서 이식제 매트릭스로 부터 생물 활성제의 방출속도를 조절하기 위한 방출속도 조절제를 또한 포함함을 특징으로 하는 조직 결함부를 치료하는 방법.
  35. (a) 이식제 전구체의 형성중에 중합체 용액을 유지시키기 위한 지지수단; (b) 이식제 전구체의 형성중에 중합체 용액을 압착시키기 위한 수단; 및 (c) 지지수단을 압착수단에 힌지연결하기 위한 수단으로 구성시키되; 힌지연결 수단은 지지수단 및 압착수단중의 하나의 변부를 따라 위치되게 하고, 압착수단은 지지수단의 중합체용액으로 회전하여 위치될 수 있게 구성시켜서 된 이식제 전구체를 형성하는 장치.
  36. (a) (i) 이식제 전구체의 형성중에 중합체 용액을 유지시키기 위한 지지수단, (ii) 이식제 전구체의 형성중에 중합체 용액을 압착시키기 위한 수단 및 (iii) 지지수단을 압착수단에 힌지연결하기 위한 수단으로 구성시키되, 힌지연결수단은 지지수단 및 압착 수단중의 하나의 변부를 따라 위치되게 하고, 압착수단은 지지수단의 중합체용액으로 회전하여 위치될 수 있게 구성시켜서 된 생체외에서 이식제 전구체를 형성하는 장치; (b) 압착수단이 지지수단으로 회진되어 위치되면 지지수단과 압착수단 사이에 간격을 유지시키기 위한 최소한 하나의 스페이서수단; (c) 생물화합성, 생물분해성, 수응고성의 열가소성 중합체와 제약적으로 허용가능한 물 혼화성 유기용매로 구성되는 중합체 혼합물을 함유하는 바이알; 및 (d) 수성매체원을 함유하는 바이알로 구성되는 키트.
  37. 제36항에 있어서, (e) 형성된 이식제 전구체를 들어올려 유지시키기 위한 수단; (f) 조직결함부 또는 이식제 전구체의 치수를 측정하기 위한 수단; (g) 이식제 전구체의 치수를 측정하기 위한 격자수단; (h) 이식제 전구체를 절단하기 위한 수단; 또는 (i) 이식제 전구체의 표면으로 부터 수성매체를 제거하기 의한 수단중 하나 이상을 또한 포함함을 특징으로 하는 키트.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940019893A 1993-09-28 1994-08-10 생물분해성 이식제 전구체 KR100248326B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019990049028A KR100263443B1 (ko) 1994-08-10 1999-10-29 생물분해성 이식제 전구체 형성용 키트

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/127,642 1993-09-28
US-08/127.642 1993-09-28
US08/127,642 US5487897A (en) 1989-07-24 1993-09-28 Biodegradable implant precursor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019990049028A Division KR100263443B1 (ko) 1994-08-10 1999-10-29 생물분해성 이식제 전구체 형성용 키트

Publications (2)

Publication Number Publication Date
KR950007878A true KR950007878A (ko) 1995-04-15
KR100248326B1 KR100248326B1 (ko) 2000-06-01

Family

ID=22431142

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940019893A KR100248326B1 (ko) 1993-09-28 1994-08-10 생물분해성 이식제 전구체

Country Status (12)

Country Link
US (4) US5487897A (ko)
EP (2) EP0649662B1 (ko)
JP (2) JP3451259B2 (ko)
KR (1) KR100248326B1 (ko)
AT (2) ATE212866T1 (ko)
AU (1) AU6614294A (ko)
CA (1) CA2117394A1 (ko)
DE (2) DE69433843T2 (ko)
DK (2) DK1147781T3 (ko)
ES (2) ES2225364T3 (ko)
PT (1) PT649662E (ko)
SI (1) SI0649662T1 (ko)

Families Citing this family (319)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5632727A (en) * 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
USRE37950E1 (en) 1990-04-24 2002-12-31 Atrix Laboratories Biogradable in-situ forming implants and methods of producing the same
US5269785A (en) * 1990-06-28 1993-12-14 Bonutti Peter M Apparatus and method for tissue removal
US6503277B2 (en) * 1991-08-12 2003-01-07 Peter M. Bonutti Method of transplanting human body tissue
EP0560014A1 (en) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
EP1125577B1 (en) * 1994-04-08 2006-02-15 QLT USA, Inc. Liquid drug delivery compositions
AU1999995A (en) * 1994-04-08 1995-11-10 Atrix Laboratories, Inc. An adjunctive polymer system for use with medical device
US6306454B1 (en) * 1994-10-17 2001-10-23 Baxter International Inc. Method for producing improved medical devices and devices so produced
US5722950A (en) * 1995-06-07 1998-03-03 Atrix Laboratories, Inc. Method for remote delivery of an aerosolized liquid
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
AU6403196A (en) 1995-06-30 1997-02-05 Baylor University Polyester/carboxylic acid composite materials
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US7888466B2 (en) 1996-01-11 2011-02-15 Human Genome Sciences, Inc. Human G-protein chemokine receptor HSATU68
US6054142A (en) * 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US5786022A (en) * 1996-10-31 1998-07-28 Ethicon, Inc. Coating mixture for surgical articles
CA2275525C (en) * 1996-12-20 2011-02-08 Kevin J. Brodbeck Gel composition and methods
US6630168B1 (en) * 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
KR100508229B1 (ko) * 1997-03-18 2005-08-17 선스타 가부시키가이샤 고체 입자 형성용 조성물
US7524335B2 (en) * 1997-05-30 2009-04-28 Smith & Nephew, Inc. Fiber-reinforced, porous, biodegradable implant device
DE59813940D1 (de) 1997-06-05 2007-04-19 Roland Bodmeier Multiphasensystem
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
US6123956A (en) * 1997-07-10 2000-09-26 Keith Baker Methods for universally distributing therapeutic agents to the brain
AUPO907697A0 (en) 1997-09-09 1997-10-02 Day, Robert Edward Chemical supplementation of bone
US6486214B1 (en) * 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US6193991B1 (en) * 1997-10-29 2001-02-27 Atul J. Shukla Biodegradable delivery systems of biologically active substances
US6733767B2 (en) 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
EP1071411B1 (en) * 1998-04-20 2007-03-14 Torrey Pines Institute For Molecular Studies Topical immunostimulation to induce langerhans cell migration
US6132360A (en) * 1998-05-22 2000-10-17 Halpern; Alan A. Magnetic stretching of magnetized neurons for spinal cord or peripheral nerve repair and regeneration
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6261583B1 (en) * 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US7335220B2 (en) 2004-11-05 2008-02-26 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US7229621B2 (en) * 1998-10-20 2007-06-12 Torrey Pines Institute For Molecular Studies Method to enhance the immunogenicity of an antigen
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6200550B1 (en) 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
US7371408B1 (en) 1999-06-07 2008-05-13 Wright Medical Technology, Inc. Bone graft substitute composition
US6179840B1 (en) 1999-07-23 2001-01-30 Ethicon, Inc. Graft fixation device and method
US20020095157A1 (en) * 1999-07-23 2002-07-18 Bowman Steven M. Graft fixation device combination
US8226598B2 (en) * 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US20020055708A1 (en) * 1999-09-24 2002-05-09 Peterson Kenneth R. Coupling syringe system and methods for obtaining a mixed composition
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
US6685928B2 (en) 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
UA78486C2 (uk) * 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20010037091A1 (en) * 1999-12-29 2001-11-01 Wironen John F. System for reconstituting pastes and methods of using same
ATE355824T1 (de) 2000-01-11 2007-03-15 Roland Bodmeier Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
WO2001051089A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
US7373197B2 (en) * 2000-03-03 2008-05-13 Intramedical Imaging, Llc Methods and devices to expand applications of intraoperative radiation probes
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
US6566144B1 (en) 2000-03-27 2003-05-20 Atrix Laboratories Cover plate for use in lyophilization
US6626870B1 (en) 2000-03-27 2003-09-30 Artix Laboratories, Inc. Stoppering method to maintain sterility
CA2406790C (en) 2000-04-19 2009-07-07 Genentech, Inc. Sustained release formulations
US7771482B1 (en) 2000-05-09 2010-08-10 Ben-Zion Karmon Method for tissue expansion and regeneration using bioresorbable inflatable devices
EP1299048A4 (en) * 2000-06-28 2005-09-28 Atul J Shukla BIODEGRADABLE VEHICLES AND SYSTEMS FOR DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES
US6719970B1 (en) * 2000-07-10 2004-04-13 Alkermes Controlled Therapeutics, Inc. Method of generating cartilage
WO2002009769A2 (en) 2000-07-27 2002-02-07 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
MXPA03000821A (es) * 2000-07-27 2004-03-18 Univ Rutgers Poliesteres y poliamidas terapeuticos.
CA2453050A1 (en) * 2000-09-06 2002-03-14 A.P. Pharma, Inc. Degradable polyacetal polymers
US6296607B1 (en) * 2000-10-20 2001-10-02 Praxis, Llc. In situ bulking device
US8470359B2 (en) 2000-11-13 2013-06-25 Qlt Usa, Inc. Sustained release polymer
DE10061297C2 (de) * 2000-12-08 2003-05-28 Siemens Ag Verfahren zur Sturkturierung eines OFETs
CA2365376C (en) 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US20020127265A1 (en) * 2000-12-21 2002-09-12 Bowman Steven M. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US9080146B2 (en) * 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
DK1372729T3 (da) * 2001-02-23 2009-06-22 Genentech Inc Nedbrydelige polymere til injektion
WO2002083194A1 (en) * 2001-04-12 2002-10-24 Therics, Inc. Method and apparatus for engineered regenerative biostructures
CA2447683A1 (en) * 2001-04-16 2002-10-24 James J. Cassidy Dense/porous structures for use as bone substitutes
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
AU2002320122B2 (en) * 2001-06-21 2007-07-26 Genentech, Inc. Sustained release formulation
US6949154B2 (en) * 2001-07-28 2005-09-27 Boehringer Ingelheim Pharma Kg Method and apparatus for sealing medicinal capsules
EP1418925A4 (en) * 2001-07-31 2009-09-02 Tyco Healthcare BIOLOGICALLY RESORBABLE ADHESIVE COMPOSITIONS AND COMPOSITIONS
US7371409B2 (en) 2001-09-06 2008-05-13 Wright Medical Technology, Inc. Bone graft substitute composition
US7204875B2 (en) * 2001-10-24 2007-04-17 Pentron Clinical Technologies, Llc Dental filling material
US7303817B2 (en) 2001-10-24 2007-12-04 Weitao Jia Dental filling material
US7204874B2 (en) 2001-10-24 2007-04-17 Pentron Clinical Technologies, Llc Root canal filling material
US7750063B2 (en) 2001-10-24 2010-07-06 Pentron Clinical Technologies, Llc Dental filling material
KR100436307B1 (ko) * 2001-11-02 2004-06-19 이진호 생분해성 고분자 다공성 지지체의 친수화, 유연화 처리방법
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
KR20040058101A (ko) * 2001-11-14 2004-07-03 알자 코포레이션 카테터 주입가능한 데포 조성물 및 그의 용도
WO2003041684A2 (en) * 2001-11-14 2003-05-22 Alza Corporation Injectable depot compositions and uses thereof
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US20030105530A1 (en) * 2001-12-04 2003-06-05 Inion Ltd. Biodegradable implant and method for manufacturing one
US6758673B2 (en) 2001-12-05 2004-07-06 Ofir Fromovich Periosteal distraction
US8501165B2 (en) 2001-12-12 2013-08-06 Promethean Surgical Devices Llc In situ bonds
US20030118651A1 (en) * 2001-12-21 2003-06-26 Jampani Hanuman B. Bio-compatible means for controlled drug delivery to tissue and method of use
US7479535B2 (en) * 2002-02-25 2009-01-20 Guilford Pharmaceuticals, Inc. Phosphorous-containing compounds with polymeric chains, and methods of making and using the same
EP1344538A1 (en) * 2002-03-14 2003-09-17 Degradable Solutions AG Porous biodegradable implant material and method for its fabrication
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
EP1489998B1 (en) 2002-03-29 2010-12-08 Wright Medical Technology, Inc. Bone graft substitute composition
AU2003247492B2 (en) * 2002-06-06 2009-05-14 The Brigham And Women's Hospital, Inc. Non-polymeric hematopoietic cell clots for delivery of active agents
US7291179B2 (en) * 2002-06-24 2007-11-06 Wright Medical Technology, Inc. Bone graft substitute composition
US6652887B1 (en) 2002-06-24 2003-11-25 Wright Medical Technology, Inc. Bone graft substitute composition
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US20080226723A1 (en) * 2002-07-05 2008-09-18 Celonova Biosciences, Inc. Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same
US7049348B2 (en) * 2002-07-06 2006-05-23 Kensey Nash Corporation Resorbable structure for treating and healing of tissue defects
US20040096476A1 (en) * 2002-07-17 2004-05-20 Uhrich Kathryn E. Therapeutic devices for patterned cell growth
US8252303B2 (en) * 2002-07-31 2012-08-28 Durect Corporation Injectable depot compositions and uses thereof
CN101057824A (zh) * 2002-07-31 2007-10-24 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
US20040078090A1 (en) 2002-10-18 2004-04-22 Francois Binette Biocompatible scaffolds with tissue fragments
US7824701B2 (en) * 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
AU2003284924B2 (en) * 2002-10-28 2009-01-08 Covidien Lp Bioabsorbable adhesive compounds
CA2513893A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7507257B2 (en) * 2003-02-04 2009-03-24 Wright Medical Technology, Inc. Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects
CN1780596B (zh) 2003-02-12 2010-12-15 辛塞拉公司 无规和非无规环氧烷聚合物共混组合物
US8197837B2 (en) 2003-03-07 2012-06-12 Depuy Mitek, Inc. Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
EP1622540A4 (en) * 2003-03-11 2009-12-30 Qlt Usa Inc FORMULATIONS FOR CELL-PLAN-DEPENDENT CANCER
US20070065652A1 (en) * 2003-03-13 2007-03-22 Willaim Marsh Rice University Composite injectable and pre-fabricated bone replacement material and method for the production of such bone replacement material
GB0307011D0 (en) 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
US7331979B2 (en) * 2003-06-04 2008-02-19 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
US9289195B2 (en) * 2003-06-04 2016-03-22 Access Closure, Inc. Auto-retraction apparatus and methods for sealing a vascular puncture
US8226715B2 (en) * 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US10583220B2 (en) 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
US8541051B2 (en) * 2003-08-14 2013-09-24 Halliburton Energy Services, Inc. On-the fly coating of acid-releasing degradable material onto a particulate
US7674753B2 (en) * 2003-09-17 2010-03-09 Halliburton Energy Services, Inc. Treatment fluids and methods of forming degradable filter cakes comprising aliphatic polyester and their use in subterranean formations
US7833944B2 (en) * 2003-09-17 2010-11-16 Halliburton Energy Services, Inc. Methods and compositions using crosslinked aliphatic polyesters in well bore applications
US7829507B2 (en) 2003-09-17 2010-11-09 Halliburton Energy Services Inc. Subterranean treatment fluids comprising a degradable bridging agent and methods of treating subterranean formations
US20050085922A1 (en) * 2003-10-17 2005-04-21 Shappley Ben R. Shaped filler for implantation into a bone void and methods of manufacture and use thereof
EP1680089B1 (en) * 2003-10-22 2013-09-11 Lidds AB Composition comprising biodegradable hydrating ceramics for controlled drug delivery
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US7316822B2 (en) 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) * 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
WO2005057165A2 (en) * 2003-12-05 2005-06-23 The Regents Of The University Of Michigan Biodegradable/bioresorbable tissue augmentation/reconstruction device
US20050129733A1 (en) * 2003-12-09 2005-06-16 Milbocker Michael T. Surgical adhesive and uses therefore
US7195068B2 (en) * 2003-12-15 2007-03-27 Halliburton Energy Services, Inc. Filter cake degradation compositions and methods of use in subterranean operations
US20070060950A1 (en) * 2003-12-24 2007-03-15 Farhad Khosravi Apparatus and methods for delivering sealing materials during a percutaneous procedure to facilitate hemostasis
US20050149117A1 (en) * 2003-12-24 2005-07-07 Farhad Khosravi Apparatus and methods for delivering sealing materials during a percutaneous procedure to facilitate hemostasis
BRPI0506983A (pt) 2004-01-20 2007-07-03 Allergan Inc composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
US7534264B2 (en) 2004-01-28 2009-05-19 Ultradent Products, Inc. Delivery system for bone growth promoting material
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US8052669B2 (en) 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048086B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US8048101B2 (en) 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8221780B2 (en) * 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8137686B2 (en) 2004-04-20 2012-03-20 Depuy Mitek, Inc. Nonwoven tissue scaffold
US20070078063A1 (en) * 2004-04-26 2007-04-05 Halliburton Energy Services, Inc. Subterranean treatment fluids and methods of treating subterranean formations
US8147865B2 (en) * 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8163030B2 (en) * 2004-05-06 2012-04-24 Degradable Solutions Ag Biocompatible bone implant compositions and methods for repairing a bone defect
US20050249791A1 (en) * 2004-05-07 2005-11-10 3M Innovative Properties Company Antimicrobial articles
EP1604693A1 (en) * 2004-06-09 2005-12-14 Scil Technology GmbH In situ forming scaffold, its manufacturing and use
EP1773350B1 (en) * 2004-07-12 2013-05-29 Allergan, Inc. Opthalmic compositions for treating ophthalmic conditions
US7547665B2 (en) * 2005-04-29 2009-06-16 Halliburton Energy Services, Inc. Acidic treatment fluids comprising scleroglucan and/or diutan and associated methods
US7621334B2 (en) * 2005-04-29 2009-11-24 Halliburton Energy Services, Inc. Acidic treatment fluids comprising scleroglucan and/or diutan and associated methods
US7475728B2 (en) * 2004-07-23 2009-01-13 Halliburton Energy Services, Inc. Treatment fluids and methods of use in subterranean formations
US8980300B2 (en) 2004-08-05 2015-03-17 Advanced Cardiovascular Systems, Inc. Plasticizers for coating compositions
US20060035039A1 (en) * 2004-08-12 2006-02-16 3M Innovative Properties Company Silver-releasing articles and methods of manufacture
US20060034899A1 (en) * 2004-08-12 2006-02-16 Ylitalo Caroline M Biologically-active adhesive articles and methods of manufacture
US8348971B2 (en) * 2004-08-27 2013-01-08 Accessclosure, Inc. Apparatus and methods for facilitating hemostasis within a vascular puncture
US20060046938A1 (en) * 2004-09-02 2006-03-02 Harris Philip C Methods and compositions for delinking crosslinked fluids
US7244270B2 (en) 2004-09-16 2007-07-17 Evera Medical Systems and devices for soft tissue augmentation
US7641688B2 (en) 2004-09-16 2010-01-05 Evera Medical, Inc. Tissue augmentation device
US7413017B2 (en) * 2004-09-24 2008-08-19 Halliburton Energy Services, Inc. Methods and compositions for inducing tip screenouts in frac-packing operations
AU2005294382A1 (en) * 2004-10-04 2006-04-20 Qlt Usa, Inc. Ocular delivery of polymeric delivery formulations
US8313763B2 (en) * 2004-10-04 2012-11-20 Tolmar Therapeutics, Inc. Sustained delivery formulations of rapamycin compounds
US7250550B2 (en) * 2004-10-22 2007-07-31 Wright Medical Technology, Inc. Synthetic bone substitute material
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9107850B2 (en) * 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9114162B2 (en) * 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
JP4885866B2 (ja) 2004-10-25 2012-02-29 セロノヴァ バイオサイエンスィズ ジャーマニー ゲーエムベーハー 治療適用および／または診断適用のための充填可能なポリホスファゼン含有粒子、ならびにその調製方法および使用方法
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
WO2006050493A2 (en) 2004-11-03 2006-05-11 The Regents Of The University Of Michigan Biodegradable implant for intertransverse process fusion
US8262693B2 (en) 2004-11-05 2012-09-11 Accessclosure, Inc. Apparatus and methods for sealing a vascular puncture
WO2006053175A2 (en) * 2004-11-10 2006-05-18 Qlt Usa Inc. A stabilized polymeric delivery system
US7648946B2 (en) * 2004-11-17 2010-01-19 Halliburton Energy Services, Inc. Methods of degrading filter cakes in subterranean formations
US7553800B2 (en) * 2004-11-17 2009-06-30 Halliburton Energy Services, Inc. In-situ filter cake degradation compositions and methods of use in subterranean formations
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US20080009423A1 (en) * 2005-01-31 2008-01-10 Halliburton Energy Services, Inc. Self-degrading fibers and associated methods of use and manufacture
US20060169448A1 (en) * 2005-02-01 2006-08-03 Halliburton Energy Services, Inc. Self-degrading cement compositions and methods of using self-degrading cement compositions in subterranean formations
US7353876B2 (en) * 2005-02-01 2008-04-08 Halliburton Energy Services, Inc. Self-degrading cement compositions and methods of using self-degrading cement compositions in subterranean formations
US7497258B2 (en) * 2005-02-01 2009-03-03 Halliburton Energy Services, Inc. Methods of isolating zones in subterranean formations using self-degrading cement compositions
US8598092B2 (en) * 2005-02-02 2013-12-03 Halliburton Energy Services, Inc. Methods of preparing degradable materials and methods of use in subterranean formations
US20070298977A1 (en) * 2005-02-02 2007-12-27 Halliburton Energy Services, Inc. Degradable particulate generation and associated methods
US20060169450A1 (en) * 2005-02-02 2006-08-03 Halliburton Energy Services, Inc. Degradable particulate generation and associated methods
US20060172894A1 (en) * 2005-02-02 2006-08-03 Halliburton Energy Services, Inc. Degradable particulate generation and associated methods
US20060172895A1 (en) * 2005-02-02 2006-08-03 Halliburton Energy Services, Inc. Degradable particulate generation and associated methods
CA2595633C (en) 2005-02-09 2013-11-19 Ahmad R. Hadba Synthetic sealants
US7506689B2 (en) * 2005-02-22 2009-03-24 Halliburton Energy Services, Inc. Fracturing fluids comprising degradable diverting agents and methods of use in subterranean formations
US8221504B2 (en) * 2005-02-23 2012-07-17 Wright Medical Technology, Inc. Coating an implant for increased bone in-growth
WO2006104901A2 (en) * 2005-03-28 2006-10-05 University Of Florida Research Foundation, Inc. Materials and methods for improved tissue engineering
US20060222596A1 (en) 2005-04-01 2006-10-05 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US20060242562A1 (en) * 2005-04-22 2006-10-26 Microsoft Corporation Embedded method for embedded interaction code array
US20090177226A1 (en) * 2005-05-05 2009-07-09 Jon Reinprecht Bioabsorbable Surgical Compositions
US8044234B2 (en) * 2005-05-05 2011-10-25 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US20100100124A1 (en) * 2005-05-05 2010-04-22 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US20100016888A1 (en) * 2005-05-05 2010-01-21 Allison Calabrese Surgical Gasket
US7608567B2 (en) * 2005-05-12 2009-10-27 Halliburton Energy Services, Inc. Degradable surfactants and methods for use
US7662753B2 (en) * 2005-05-12 2010-02-16 Halliburton Energy Services, Inc. Degradable surfactants and methods for use
US20060276345A1 (en) * 2005-06-07 2006-12-07 Halliburton Energy Servicers, Inc. Methods controlling the degradation rate of hydrolytically degradable materials
US7595280B2 (en) * 2005-08-16 2009-09-29 Halliburton Energy Services, Inc. Delayed tackifying compositions and associated methods involving controlling particulate migration
US7484564B2 (en) * 2005-08-16 2009-02-03 Halliburton Energy Services, Inc. Delayed tackifying compositions and associated methods involving controlling particulate migration
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US20070100199A1 (en) * 2005-11-03 2007-05-03 Lilip Lau Apparatus and method of delivering biomaterial to the heart
US20070049501A1 (en) * 2005-09-01 2007-03-01 Halliburton Energy Services, Inc. Fluid-loss control pills comprising breakers that comprise orthoesters and/or poly(orthoesters) and methods of use
US8025903B2 (en) 2005-09-09 2011-09-27 Wright Medical Technology, Inc. Composite bone graft substitute cement and articles produced therefrom
BRPI0617086B8 (pt) 2005-09-09 2021-06-22 Agnovos Healtcare Llc cimento composto substituto de enxerto ósseo e artigos dele originados
US7713916B2 (en) 2005-09-22 2010-05-11 Halliburton Energy Services, Inc. Orthoester-based surfactants and associated methods
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
EA015860B1 (ru) 2005-10-13 2011-12-30 Хьюман Дженом Сайенсиз, Инк. Способы лечения аутоиммунных заболеваний при использовании антагониста нейтрокина-альфа
US7461697B2 (en) * 2005-11-21 2008-12-09 Halliburton Energy Services, Inc. Methods of modifying particulate surfaces to affect acidic sites thereon
US7858078B2 (en) 2005-12-06 2010-12-28 Tyco Healthcare Group Lp Bioabsorbable surgical composition
AU2006321914B2 (en) * 2005-12-06 2012-01-19 Covidien Lp Bioabsorbable compounds and compositions containing them
US7998466B2 (en) * 2005-12-06 2011-08-16 Tyco Healthcare Group Lp Biocompatible tissue sealants and adhesives
CA2628579C (en) * 2005-12-06 2014-07-08 Tyco Healthcare Group Lp Carbodiimide crosslinking of functionalized polethylene glycols
CA2628575C (en) * 2005-12-06 2014-07-08 Tyco Healthcare Group Lp Biocompatible surgical compositions
US20070135566A1 (en) * 2005-12-08 2007-06-14 Tyco Healthcare Group Lp Viscosity-reduced sprayable compositions
AU2006321856B2 (en) * 2005-12-08 2013-01-31 Covidien Lp Biocompatible surgical compositions
CA2630327C (en) 2005-12-08 2015-05-26 Tyco Healthcare Group Lp Biocompatible surgical compositons
MX2008009125A (es) 2006-01-18 2008-10-23 Qps Llc Composiciones farmaceuticas con estabilidad mejorada.
US20070173416A1 (en) * 2006-01-20 2007-07-26 Halliburton Energy Services, Inc. Well treatment compositions for use in acidizing a well
CA2573472A1 (en) * 2006-01-23 2007-07-23 Tyco Healthcare Group Lp Biodegradable hemostatic compositions
US20070178159A1 (en) * 2006-01-30 2007-08-02 Alza Corporation In-Situ Forming Porous Scaffold
US20070184087A1 (en) * 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
US8591875B2 (en) * 2006-02-22 2013-11-26 Covidien Lp Biodegradable phosphoester polyamines
US7608566B2 (en) * 2006-03-30 2009-10-27 Halliburton Energy Services, Inc. Degradable particulates as friction reducers for the flow of solid particulates and associated methods of use
BRPI0709348A2 (pt) * 2006-03-31 2011-07-12 Csir material de expansão de tecido leve e composição de expansão de tecido leve injetável
US7872068B2 (en) 2006-05-30 2011-01-18 Incept Llc Materials formable in situ within a medical device
CN101511380B (zh) * 2006-07-11 2012-12-12 昌达生物科技公司 用于持续释放递送肽的药物组合物
US20080026960A1 (en) * 2006-07-25 2008-01-31 Halliburton Energy Services, Inc. Degradable particulates and associated methods
US20080026955A1 (en) * 2006-07-25 2008-01-31 Halliburton Energy Services, Inc. Degradable particulates and associated methods
US20080026959A1 (en) * 2006-07-25 2008-01-31 Halliburton Energy Services, Inc. Degradable particulates and associated methods
US8329621B2 (en) * 2006-07-25 2012-12-11 Halliburton Energy Services, Inc. Degradable particulates and associated methods
EP2517663B1 (en) * 2006-08-22 2017-06-14 Mitsubishi Electric Corporation Implant material and implant-material fabrication method
EP2102144A4 (en) 2006-09-13 2011-03-23 Univ Rutgers ACTIVE SUBSTANCES AND THEIR OLIGOMERS AND POLYMERS
US7455112B2 (en) * 2006-09-29 2008-11-25 Halliburton Energy Services, Inc. Methods and compositions relating to the control of the rates of acid-generating compounds in acidizing operations
US9289279B2 (en) * 2006-10-06 2016-03-22 Promethean Surgical Devices, Llc Apparatus and method for limiting surgical adhesions
US8076448B2 (en) * 2006-10-11 2011-12-13 Tolmar Therapeutics, Inc. Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
US7686080B2 (en) * 2006-11-09 2010-03-30 Halliburton Energy Services, Inc. Acid-generating fluid loss control additives and associated methods
US8220548B2 (en) 2007-01-12 2012-07-17 Halliburton Energy Services Inc. Surfactant wash treatment fluids and associated methods
PL2148691T3 (pl) 2007-02-05 2015-12-31 Apellis Pharmaceuticals Inc Analogi kompstatyny do stosowania w leczeniu stanów zapalnych układu oddechowego
ES2755374T3 (es) 2007-02-15 2020-04-22 Tolmar Therapeutics Inc Poli(lactida/glicolida) de descarga lenta y métodos para producir polímeros
US20110123476A1 (en) * 2007-05-24 2011-05-26 Mbiya Kapiamba Adhesive Formulations
US10010612B2 (en) 2007-05-25 2018-07-03 Indivior Uk Limited Sustained delivery formulations of risperidone compounds
US7858835B2 (en) * 2007-06-27 2010-12-28 Tyco Healthcare Group Lp Foam control for synthetic adhesive/sealant
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US20090041824A1 (en) * 2007-08-07 2009-02-12 Arsenal Medical, Inc. Method and apparatus for composite drug delivery medical devices
US20090062157A1 (en) * 2007-08-30 2009-03-05 Halliburton Energy Services, Inc. Methods and compositions related to the degradation of degradable polymers involving dehydrated salts and other associated methods
US8470360B2 (en) * 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
US20090111763A1 (en) * 2007-10-26 2009-04-30 Celonova Biosciences, Inc. Loadable polymeric particles for bone augmentation and methods of preparing and using the same
US20090110738A1 (en) * 2007-10-26 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same
US20090110731A1 (en) * 2007-10-30 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same
US20090110730A1 (en) * 2007-10-30 2009-04-30 Celonova Biosciences, Inc. Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same
WO2009059217A2 (en) * 2007-11-02 2009-05-07 Incept, Llc Apparatus and methods for sealing a vascular puncture
US8500947B2 (en) 2007-11-15 2013-08-06 Covidien Lp Speeding cure rate of bioadhesives
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
US20090197780A1 (en) * 2008-02-01 2009-08-06 Weaver Jimmie D Ultrafine Grinding of Soft Materials
US20090198329A1 (en) 2008-02-01 2009-08-06 Kesten Randy J Breast implant with internal flow dampening
US8029533B2 (en) 2008-04-04 2011-10-04 Accessclosure, Inc. Apparatus and methods for sealing a vascular puncture
US9364206B2 (en) 2008-04-04 2016-06-14 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
US8006760B2 (en) 2008-04-10 2011-08-30 Halliburton Energy Services, Inc. Clean fluid systems for partial monolayer fracturing
US7906464B2 (en) 2008-05-13 2011-03-15 Halliburton Energy Services, Inc. Compositions and methods for the removal of oil-based filtercakes
CA2726763A1 (en) * 2008-06-03 2009-12-10 Tolmar Therapeutics, Inc. Controlled release copolymer formulation with improved release kinetics
ES2569556T3 (es) 2008-06-03 2016-05-11 Indivior Uk Limited Complejo de inclusión de hidrogel deshidratado de un agente bioactivo con sistema fluido de administración de medicamento
CA2730760A1 (en) * 2008-07-16 2010-01-21 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles containing bioactive peptides
CA2730745A1 (en) 2008-07-17 2010-01-21 Merial Limited Long-acting injectable analgesic formulations for animals
US7833943B2 (en) 2008-09-26 2010-11-16 Halliburton Energy Services Inc. Microemulsifiers and methods of making and using same
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
WO2010093873A2 (en) 2009-02-12 2010-08-19 Incept, Llc Drug delivery through hydrogel plugs
EP2396035A4 (en) 2009-02-12 2012-09-12 Human Genome Sciences Inc USE OF ANTAGONISTS OF PROTEIN STIMULATING LYMPHOCYTES B TO PROMOTE GRAFT TOLERANCE
US20100212906A1 (en) * 2009-02-20 2010-08-26 Halliburton Energy Services, Inc. Method for diversion of hydraulic fracture treatments
US8574612B2 (en) * 2009-03-04 2013-11-05 Boston Scientific Scimed, Inc. Medical devices having a coating of biologic macromolecules
US8377316B2 (en) * 2009-04-30 2013-02-19 Xerox Corporation Structure and method for creating surface texture of compliant coatings on piezo ink jet imaging drums
EP3153194B1 (en) * 2009-05-04 2019-04-10 Incept, LLC Biomaterials for track and puncture closure
WO2010141475A1 (en) * 2009-06-01 2010-12-09 Tyrx Pharma, Inc. Compositions and methods for preventing sternal wound infections
US8082992B2 (en) 2009-07-13 2011-12-27 Halliburton Energy Services, Inc. Methods of fluid-controlled geometry stimulation
WO2011035020A1 (en) 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
DE102010020940B4 (de) * 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US20120040013A1 (en) * 2010-08-10 2012-02-16 LifeCell Corporation. Regenerative Tissue Scaffolds
US8741317B2 (en) 2010-08-19 2014-06-03 Rutgers, The State University Of New Jersey Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
GB201016436D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Method of making solid beads
GB201016433D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Apparatus and method for making solid beads
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
US9820728B2 (en) 2011-01-19 2017-11-21 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
EP2665425B1 (en) 2011-01-19 2018-08-22 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
JP6189827B2 (ja) * 2011-04-13 2017-08-30 ニュー ジャージー インスティテューツ オブ テクノロジー 骨修復のためのエレクトロスピニングによる生分解性の足場のためのシステムと方法
US9265830B2 (en) 2011-04-20 2016-02-23 Warsaw Orthopedic, Inc. Implantable compositions and methods for preparing the same
US9386968B2 (en) 2011-05-11 2016-07-12 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
US9216181B2 (en) 2011-06-08 2015-12-22 Southwest Research Institute BMP-2 upregulating compounds for healing bone tissue and screening methods for selecting such compounds
US10232086B2 (en) * 2011-11-16 2019-03-19 Empire Technology Development Llc Three-dimensional porous biodegradable cell scaffold
CA2858161C (en) 2011-12-05 2020-03-10 Incept, Llc Medical organogel processes and compositions
US20150031772A1 (en) * 2012-02-17 2015-01-29 Bacterin International, Inc. Adjustable bioactive agent dispersion within a polymeric coating
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair
KR101395712B1 (ko) 2013-03-18 2014-05-19 주식회사 엘앤씨바이오 진피조직체의 동결건조용 지그
US9862672B2 (en) 2013-05-29 2018-01-09 Rutgers, The State University Of New Jersey Antioxidant-based poly(anhydride-esters)
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US20170080125A1 (en) * 2014-03-17 2017-03-23 The Penn State Research Foundation Methods of Promoting Bone Growth and Healing
US10023521B2 (en) 2014-06-13 2018-07-17 Rutgers, The State University Of New Jersey Process and intermediates for preparing poly(anhydride-esters)
US20160106804A1 (en) 2014-10-15 2016-04-21 Yuhua Li Pharmaceutical composition with improved stability
CA2979982A1 (en) * 2015-03-17 2016-09-22 President And Fellows Of Harvard College Automated membrane fabrication system
JP6930918B6 (ja) 2015-04-10 2021-12-15 ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー コウジ酸ポリマー
IL243401A (en) 2015-12-29 2017-12-31 Zion Karmon Ben Instruments and methods for lifting Schneider membrane
IL248472A0 (en) 2016-10-13 2017-01-31 Zion Karmon Ben Devices for tissue growth
CA3084339A1 (en) 2017-12-18 2019-06-27 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical compositions having a selected release duration
US10926005B2 (en) * 2018-12-21 2021-02-23 BioSapien Inc. Drug-eluting surgical articles with a plurality of geometric elements
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法
CN114159103B (zh) * 2021-11-23 2022-09-13 深圳市华晨阳科技有限公司 一种可降解的一次性采样口腔拭子

Family Cites Families (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2155658A (en) * 1936-01-08 1939-04-25 Chemische Forschungs Gmbh Surgical and medical preparations
BE565269A (ko) * 1957-03-27
US3328246A (en) * 1957-08-20 1967-06-27 Bicrex Lab Ltd Dental compositions and methods of making same
US3218283A (en) * 1962-07-26 1965-11-16 Monsanto Co Novel solutions of poly-(acrylic anhydride) and poly-(methacrylic anhydride) polymers
US3219527A (en) * 1963-06-17 1965-11-23 Loyola University Peridontal pack or dressing composition
US3463158A (en) * 1963-10-31 1969-08-26 American Cyanamid Co Polyglycolic acid prosthetic devices
US3520949A (en) * 1966-07-26 1970-07-21 Nat Patent Dev Corp Hydrophilic polymers,articles and methods of making same
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3760034A (en) * 1971-01-26 1973-09-18 Union Carbide Corp Graft copolymers of lactone polyesters
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
US3696811A (en) * 1971-06-17 1972-10-10 Squibb & Sons Inc Periodontal bandage and backing therefor
US3975350A (en) * 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
US4450150A (en) * 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US3919773A (en) * 1973-12-20 1975-11-18 Sybron Corp Direct moldable implant material
US3939111A (en) * 1974-07-01 1976-02-17 The B. F. Goodrich Company Stable polyurethane solutions
US3935308A (en) * 1974-08-08 1976-01-27 The United States Of America As Represented By The Secretary Of The Navy Wound covering and method of application
US3931678A (en) * 1974-09-24 1976-01-13 Loctite (Ireland) Limited Dental filling method and composition formed thereby
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
CH625702A5 (ko) * 1977-01-18 1981-10-15 Delalande Sa
US4127127A (en) * 1977-05-23 1978-11-28 Alza Corporation Therapeutic systems made from certain segmented copolyesters
US4148871A (en) * 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers
DE2917037C2 (de) 1979-04-27 1980-12-11 Josef Dipl.-Chem. Dr. 8000 Muenchen Gaensheimer Parenteral arzneimittelhaltige partiell resorbierbare Mehrkomponentenmasse auf Basis von polymeren Stoffen
US4619989A (en) * 1981-05-05 1986-10-28 The Regents Of The University Of Cal. Bone morphogenetic protein composition
US4761471A (en) * 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4789732A (en) * 1980-08-04 1988-12-06 Regents Of The University Of California Bone morphogenetic protein composition
US4455256A (en) * 1981-05-05 1984-06-19 The Regents Of The University Of California Bone morphogenetic protein
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US4408023A (en) * 1980-11-12 1983-10-04 Tyndale Plains-Hunter, Ltd. Polyurethane diacrylate compositions useful for contact lenses and the like
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
JPS57110254A (en) * 1980-12-29 1982-07-09 Teijin Ltd Coating agent of injured membrane part of oral cavity
US4793336A (en) * 1981-03-25 1988-12-27 Wang Paul Y Wound coverings and processes for their preparation
US4447562A (en) * 1981-07-15 1984-05-08 Ivani Edward J Amino-polysaccharides and copolymers thereof for contact lenses and ophthalmic compositions
FR2515955B1 (fr) * 1981-11-11 1987-11-20 South African Inventions Implant chirurgical
US4582640A (en) * 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4570629A (en) * 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
DE3377462D1 (en) * 1982-04-07 1988-09-01 Bernard Paul Philippe Feinmann Improved material and method for dentistry
DE3378250D1 (en) * 1982-04-22 1988-11-24 Ici Plc Continuous release formulations
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US4439420A (en) * 1982-11-16 1984-03-27 Ethicon, Inc. Absorbable hemostatic composition
US5286763A (en) * 1983-03-22 1994-02-15 Massachusetts Institute Of Technology Bioerodible polymers for drug delivery in bone
US4904478A (en) * 1983-08-11 1990-02-27 Mission Pharmacal Company Slow-release sodium fluoride tablet and method for treatment of osteoporosis
US4795804A (en) * 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4932973A (en) * 1983-09-30 1990-06-12 El Gendler Cartilage and bone induction by artificially perforated organic bone matrix
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
US4526909A (en) * 1984-01-09 1985-07-02 Regents Of The University Of California Polymethylmethacrylate delivery system for bone morphogenetic protein
SE452404B (sv) * 1984-02-03 1987-11-30 Medinvent Sa Flerskiktat protesmaterial samt forfarande for dess framstellning
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US4663077A (en) * 1984-06-11 1987-05-05 Morton Thiokol Inc. Microbiocidal compositions comprising an aryl alkanol and a microbiocidal compound dissolved therein
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
IN164495B (ko) * 1984-07-06 1989-03-25 Gore & Ass
EP0169016B2 (en) * 1984-07-16 2004-04-28 Celtrix Pharmaceuticals, Inc. Polypeptide cartilage-inducing factors found in bone
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
US4614787A (en) * 1984-11-13 1986-09-30 Thermedics, Inc. Drug dispensing wound dressing
US4687768A (en) * 1984-12-21 1987-08-18 The Procter & Gamble Company Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism
US4595713A (en) * 1985-01-22 1986-06-17 Hexcel Corporation Medical putty for tissue augmentation
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
EP0200508B1 (en) * 1985-04-27 1991-10-02 Nitto Denko Corporation Adhesive oral bandages and oral pharmaceutical preparations
US4857456A (en) * 1985-04-30 1989-08-15 The Regents Of The University Of California Assay of Bone morphogenetic protein (BMP) and anti-BMP antibody for the diagnosis of bone disorders
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
DE3519361A1 (de) * 1985-05-30 1986-12-04 Boehringer Ingelheim International GmbH, 6507 Ingelheim (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
US4702917A (en) * 1985-11-18 1987-10-27 Research Triangle Institute Porous bioabsorbable polyesters
CH667874A5 (fr) * 1985-12-19 1988-11-15 Battelle Memorial Institute Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments.
US4767861A (en) * 1986-01-28 1988-08-30 Vipont Laboratories Recovery of benzo-c-phenanthridine alkaloids
US4774227A (en) * 1986-02-14 1988-09-27 Collagen Corporation Collagen compositions for bone repair containing autogeneic marrow
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4857602A (en) * 1986-09-05 1989-08-15 American Cyanamid Company Bioabsorbable surgical suture coating
FI81010C (fi) * 1986-09-05 1990-09-10 Biocon Oy Stoedstruktur foer bentransplantat.
US4905680A (en) * 1986-10-27 1990-03-06 Johnson & Johnson Orthopaedics, Inc. Absorbable bone plate
US4902296A (en) * 1986-10-29 1990-02-20 The University Of Virginia Alumni Patents Foundation Use of demineralized bone matrix in the repair of segmental defects
GB8626623D0 (en) * 1986-11-07 1986-12-10 Shirley Inst Vascular prosthesis
US4846165A (en) * 1986-11-26 1989-07-11 Dentsply Research & Development Corp. Wound dressing membrane
US4981696A (en) * 1986-12-22 1991-01-01 E. I. Du Pont De Nemours And Company Polylactide compositions
US4800219A (en) * 1986-12-22 1989-01-24 E. I. Du Pont De Nemours And Company Polylactide compositions
US4983689A (en) * 1987-05-07 1991-01-08 Yu Simon H Process for making macromolecular monomers of polylactones with terminal acryloyl unsaturation and block copolymers thereof
IL86802A0 (en) * 1987-06-30 1988-11-30 Vipont Pharma Drug delivery devices
US5013553A (en) * 1987-06-30 1991-05-07 Vipont Pharmaceutical, Inc. Drug delivery devices
SE8802414D0 (sv) * 1988-06-27 1988-06-28 Astra Meditec Ab Nytt kirurgiskt material
US4912141A (en) * 1987-07-28 1990-03-27 Kronman Joseph H Fibrous and cartilaginous tissue replacement
US5019379A (en) * 1987-07-31 1991-05-28 Massachusetts Institute Of Technology Unsaturated polyanhydrides
US4911931A (en) * 1987-08-03 1990-03-27 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
US4804691A (en) * 1987-08-28 1989-02-14 Richards Medical Company Method for making a biodegradable adhesive for soft living tissue
DE3734223A1 (de) * 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem
US5149052A (en) * 1987-11-16 1992-09-22 Kingston Technologies, Inc. Precision molding of polymers
US4920203A (en) * 1987-12-17 1990-04-24 Allied-Signal Inc. Medical devices fabricated from homopolymers and copolymers having recurring carbonate units
US4961707A (en) * 1987-12-22 1990-10-09 University Of Florida Guided periodontal tissue regeneration
US4916241A (en) * 1988-06-06 1990-04-10 American Home Products Corporation Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones
JP2709349B2 (ja) * 1988-08-31 1998-02-04 株式会社 ジーシー 歯周組織再生用素材
US5250584A (en) * 1988-08-31 1993-10-05 G-C Dental Industrial Corp. Periodontium-regenerative materials
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5324520A (en) * 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
SE8804641D0 (sv) * 1988-12-23 1988-12-23 Procordia Oratech Ab Surgical barrier
US5007940A (en) * 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5077049A (en) * 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
US5198220A (en) * 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP0560014A1 (en) 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation

Also Published As

Publication number Publication date
CA2117394A1 (en) 1995-03-29
JP3451259B2 (ja) 2003-09-29
DK1147781T3 (da) 2004-10-18
JPH07163654A (ja) 1995-06-27
DE69433843D1 (de) 2004-07-15
DE69429801T2 (de) 2002-07-18
US6071530A (en) 2000-06-06
EP0649662A1 (en) 1995-04-26
EP1147781A1 (en) 2001-10-24
US5660849A (en) 1997-08-26
ATE268611T1 (de) 2004-06-15
DE69429801D1 (de) 2002-03-21
ATE212866T1 (de) 2002-02-15
SI0649662T1 (en) 2002-06-30
ES2173102T3 (es) 2002-10-16
DK0649662T3 (da) 2002-05-13
US20020001608A1 (en) 2002-01-03
KR100248326B1 (ko) 2000-06-01
AU6614294A (en) 1995-04-13
ES2225364T3 (es) 2005-03-16
DE69433843T2 (de) 2005-06-23
US5487897A (en) 1996-01-30
EP0649662B1 (en) 2002-02-06
EP1147781B1 (en) 2004-06-09
JP2003093498A (ja) 2003-04-02
US6395293B2 (en) 2002-05-28
PT649662E (pt) 2002-07-31

Similar Documents

Publication Publication Date Title
KR950007878A (ko) 생물분해성 이식제 전구체
DE60108258T2 (de) Selbstklebende, hydratierbare matrix für therapeutische anwendungen
JP2001508756A (ja) 非ポリマー持続性解離供給システム
DE69732721T2 (de) Biologisch abbaubare kunstoff-folien
JP4686653B2 (ja) 低い初期薬物噴出性を有する制御放出性液状デリバリー組成物
EP0086093B1 (en) Long-lasting three layered pharmaceutical film preparations
CA2273017C (fr) Dispositif d'administration locale de formulations solides ou semi-solides, formulations retard pour administration parenterale et procede de preparation
Maurer et al. Vicryl (polyglactin 910) mesh as a dural substitute
DE69724780T2 (de) Polysaccharidschwämme für zellkultur und transplantation
Park et al. Porous poly (L-lactide) membranes for guided tissue regeneration and controlled drug delivery: membrane fabrication and characterization
JP2003514006A (ja) 生物分解性ポリマー組成物
KR970702029A (ko) 액체 전달 조성물(Liquid delivery compositions)
US20070275040A1 (en) Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
JP2002537221A (ja) 成形可能な固体のデリバリーシステム
JP2001515456A (ja) 口腔の苦痛状態を治療するための経口投与および方法
EP1616584A1 (en) Biodegradable film having honeycomb structure
JP2001516728A (ja) デバイスとしての高粘性液状コントロールドデリバリーシステム
KR930007464A (ko) 생분해성 중합체 조성물
DE69721759T2 (de) Transdermale vorrichtung
EP0809489B1 (de) Arzneiform zur abgabe von kollagenase an wunden und verfahren zu ihrer herstellung
JP2007503221A (ja) ポリヒドロキシアルカノエート神経再生デバイス
KR100263443B1 (ko) 생물분해성 이식제 전구체 형성용 키트
DE69630051T2 (de) Durch wasser aktivierbare amethocain enthaltende klebematrix
JP6564983B2 (ja) 薬剤徐放デバイス
DE10228078B3 (de) Mittel zur Beschichtung von Implantaten sowie Verfahren zur Beschichtung von Implantaten

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
A107 Divisional application of patent
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121122

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20131119

Year of fee payment: 15